Market Overview:
The global nucleic acid extraction instrument market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for nucleic acid extraction instruments from hospitals, clinics, and drug stores. Additionally, the growing awareness about nucleic acid extraction among researchers and scientists is also contributing to the growth of this market. However, factors such as high cost of instruments and lack of skilled professionals are restraining the growth of this market. On the basis of type, the global nucleic acid extraction instrument market can be segmented into injection-based and topical-based instruments. The injection-based segment is expected to account for a larger share in terms of revenue in 2018 owing to its wide adoption across hospitals and clinics for extracting DNA or RNA from various samples such as blood or tissue specimens. On the other hand, topical-based instruments are witnessing a higher adoption rate due their ease of use and low cost as compared with injection-based ones. Based on application, hospitals accounted for majority share in 2017 owing to rising number cancer patients who require isolation & purification procedures prior gene therapy treatment & diagnosis purposes which further boosts demand for nuclease enzymes globally followed by clinics then drug store .
Product Definition:
A nucleic acid extraction instrument is a device used to isolate and purify nucleic acids from biological samples. The importance of this type of instrument is that it allows for the study of genetic material in a variety of organisms. Additionally, it can be used in the diagnosis and treatment of various diseases.
Injection:
Injection is a technique used in molecular biology for the transfer of nucleic acids from a sample into an analytical instrument. In this process, the nucleic acid is converted to an ionic form that can be directly injected into the device. This method reduces errors and provides better control over analysis as compared to other methods such as elution or lysis.
Topical:
Topical is a method used for the treatment of skin diseases and consists of drugs that are applied to the skin. Topical drugs can be absorbed by the body through either dermal or epidermal routes. The topical route is preferred over other routes because it reduces systemic exposure to drugs, thus avoiding side effects.
The most commonly used topical drug for DNA extraction from blood samples includes Ethambutal (EMB) and Adozel (DOZ).
Application Insights:
The hospital segment dominated the global market in 2017. This is owing to the rising prevalence of various chronic diseases, which necessitates frequent blood tests and other diagnostic procedures, thereby driving demand for nucleic acid extraction instruments in hospitals and clinics. Moreover, a rise in investment by governments for developing advanced healthcare facilities along with an increase in spending on diagnostics are further expected to drive growth over the forecast period.
The drug store segment is anticipated to witness lucrative growth over the forecast period due to factors such as increasing adoption of these devices across emerging economies due to low cost treatment options coupled with easy access resulting from high population density.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as local presence of major players, high disposable income, and availability of advanced diagnostic techniques. Moreover, increasing government initiatives for the adoption of genetic tests is also expected to drive regional growth over the forecast period. For instance, in May 2018 FDA approved a new NGS platform from Illumina that includes MiSeq Reagents & Software v2 kit and MiPlex 2 reagents & software version 2 kits for whole-genome amplification (WGA) and sequencing applications respectively.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising prevalence of chronic diseases coupled with growing healthcare expenditure in emerging economies such as China and India.
Growth Factors:
- Increasing demand for nucleic acid extraction from various sample types for downstream applications such as sequencing, genotyping, and gene expression analysis.
- Growing number of research institutes and biotechnology companies that are using nucleic acid extraction techniques for their research work.
- Technological advancements in nucleic acid extraction instruments that are making the process faster, easier, and more efficient.
- Rising funding for life science research projects that is driving the adoption of nucleic acid extraction techniques and instruments.
- Growing awareness about the benefits of using nucleic acids extracted from samples for diagnostic and prognostic purposes
Scope Of The Report
Report Attributes
Report Details
Report Title
Nucleic Acid Extraction Instrument Market Research Report
By Type
Injection, Topical
By Application
Hospital, Clinics, Drug Store, Others
By Companies
Merck, Roche, SP (Brinny) Company, Anke Bio, Sinopharm, Kexing Biopharm, Kawin, Hainan Unipul Pharmaceutical, Tri-Prime Gene, Amoytop Biotech, Changchun Institute of Biological Products
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Nucleic Acid Extraction Instrument Market Report Segments:
The global Nucleic Acid Extraction Instrument market is segmented on the basis of:
Types
Injection, Topical
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Drug Store, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Roche
- SP (Brinny) Company
- Anke Bio
- Sinopharm
- Kexing Biopharm
- Kawin
- Hainan Unipul Pharmaceutical
- Tri-Prime Gene
- Amoytop Biotech
- Changchun Institute of Biological Products
Highlights of The Nucleic Acid Extraction Instrument Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection
- Topical
- By Application:
- Hospital
- Clinics
- Drug Store
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nucleic Acid Extraction Instrument Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A nucleic acid extraction instrument is a device used to extract DNA or RNA from a sample.
Some of the major players in the nucleic acid extraction instrument market are Merck, Roche, SP (Brinny) Company, Anke Bio, Sinopharm, Kexing Biopharm, Kawin, Hainan Unipul Pharmaceutical, Tri-Prime Gene, Amoytop Biotech, Changchun Institute of Biological Products.
The nucleic acid extraction instrument market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nucleic Acid Extraction Instrument Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Nucleic Acid Extraction Instrument Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Nucleic Acid Extraction Instrument Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Nucleic Acid Extraction Instrument Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Nucleic Acid Extraction Instrument Market Size & Forecast, 2020-2028 4.5.1 Nucleic Acid Extraction Instrument Market Size and Y-o-Y Growth 4.5.2 Nucleic Acid Extraction Instrument Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Injection
5.2.2 Topical
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Drug Store
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nucleic Acid Extraction Instrument Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nucleic Acid Extraction Instrument Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Injection
9.6.2 Topical
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Drug Store
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Injection
10.6.2 Topical
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Drug Store
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Injection
11.6.2 Topical
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Drug Store
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Injection
12.6.2 Topical
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Drug Store
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Injection
13.6.2 Topical
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Drug Store
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nucleic Acid Extraction Instrument Market: Competitive Dashboard
14.2 Global Nucleic Acid Extraction Instrument Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Roche
14.3.3 SP (Brinny) Company
14.3.4 Anke Bio
14.3.5 Sinopharm
14.3.6 Kexing Biopharm
14.3.7 Kawin
14.3.8 Hainan Unipul Pharmaceutical
14.3.9 Tri-Prime Gene
14.3.10 Amoytop Biotech
14.3.11 Changchun Institute of Biological Products